Author: Zhang Chunjiao Publisher: QYResearch Published Date: Apr 28 2017
Recently, QYResearch published a report on ambulatory surgical centers (ASCs) market. The global ambulatory surgical centers (ASCs) market is currently witnessing relatively fast growth mainly due to an increasing demand for quick, cost-effective, and high-quality medical services as a viable alternative to inpatient care. In terms of revenue the global ambulatory surgical centers market is projected to expand at a CAGR of 3.95% during the forecast period (2012–2022) and is expected to be valued at 94.5 B USD by the end of 2022– projecting a 1.47X increase during this period. Market growth is likely to be driven largely by the rise in healthcare spending along with a growing number of ASCs.
The global ambulatory surgical centers market is highly fragmented with top five leading companies, which include AmSurg, THC, HCA Healthcare, Mednax and Team Health accounting for approximately 14% of the overall market in 2017. In this report, the major players include AmSurg, THC, HCA Healthcare, Mednax, Team Health, Surgical Care Affiliates, QHC, Surgery Partners, Medical Facilities, Terveystalo Healthcare, SurgCenter Development, Healthway Medical, Eifelhoehen-Klinik and etc.
The global ambulatory surgical centers market is segmented based on center type into single specialty centers and multi-specialty centers; based on modality into hospital-based ambulatory surgical centers and freestanding ambulatory surgical centers; based on services into diagnostic services and surgical services; and based on specialty area into gastroenterology, ophthalmology, orthopedics, pain/neurology, urology, dermatology, and others. The hospital-based ambulatory surgical centers segment is expected to witness relatively higher growth rates in terms of value in the global ambulatory surgical centers market over the forecast period. Currently, the gastroenterology (revenue market share 31.6% in 2017) specialty area segment accounts for a relatively higher revenue share, followed by ophthalmology (revenue market share 28.3% in 2017) and pain/neurology segments (revenue market share 21.6% in 2017).
This article was first released by QYResearch analyst, if reproduced, please indicate the source.
Media Contact: email@example.com
More details about the report: www.qyresearchglobal.com